(Q53334042)
Statements
Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemotherapy: results of a phase II study. (English)
P Gascon
R Pirker
L Durrwell
24 March 2010
21
10
2029-2039